What is the all-time high and low for Bristol Myers Squibb?
The all-time high Bristol Myers Squibb stock closing price was 77.94 on October 28, 1999. The Bristol Myers Squibb 52-week high stock price is 69.75, which is 9.8% above the current share price. The Bristol Myers Squibb 52-week low stock price is 53.22, which is 16.2% below the current share price.
Is Bristol-Myers Squibb (BMY) outpacing stock market gains?
Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know. In the latest trading session, Bristol-Myers Squibb (BMY) closed at $49.24, marking a +1.4% move from the previous day.
How has covid-19 affected Bristol-Myers Squibb's stock?
Bristol-Myers Squibb's stock was trading at $108.24 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BMY shares have decreased by 41.7% and is now trading at $63.13. View which stocks have been most impacted by COVID-19.
What are Wall Street's price targets for Bristol-Myers Squibb's stock?
13 Wall Street analysts have issued 1-year price targets for Bristol-Myers Squibb's shares. Their forecasts range from $70.00 to $78.00. On average, they anticipate Bristol-Myers Squibb's stock price to reach $74.30 in the next twelve months.
See more
Is BMY a buy today?
No, in September 2021, BMY stock isn't a buy.
How much is Bristol Myers stock worth?
$ 76.00CloseChgChg %$75.651.642.22%
What did Bristol Myers Stock Close at?
Performance OutlookPrevious Close73.74Bid72.89 x 2200Ask72.99 x 1400Day's Range72.92 - 74.2952 Week Range53.22 - 80.593 more rows
Is Bristol Myers Squibb still in business?
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb is committed to patient care and is constantly working to shape the future of cancer care and improve the lives of cancer patients.
What is Dow Chemical stock price?
Performance OutlookPrevious Close52.45Bid52.40 x 900Ask52.70 x 900Day's Range51.81 - 52.6752 Week Range48.27 - 71.863 more rows
What is Bristol Myers Squibb known for?
The company is known for biological and pharmaceutical research, producing the antipsychotic Abilify (which it helps market) and its blood thinners Plavix and Eliquis, as well as cancer drug Opdivo. Sales for Opdivo alone went from $942 million in 2015 to $3.8 billion in 2016.
Where can I find stock prices?
The 10 Best Ways to Check Stock Prices OnlineMarketWatch.CNN Markets.U.S News.Google Finance.Investopedia.6. Yahoo! Finance.Stocks (Mac)Nasdaq.More items...•
Is BMS profitable?
That implies it has very good cash conversion, and that its earnings in the last year actually significantly understate its free cash flow. The company produced free cash flow of US$12b during the period, dwarfing its reported profit of -US$5.08b.
Is BMS a Fortune 100 company?
Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2021, it had a total revenue of $46.4 billion.
Is BMS a good company?
Is Bristol-Myers Squibb a good company to work for? Bristol-Myers Squibb has an overall rating of 4.1 Average Rating out of 5, based on over 196 Bristol-Myers Squibb Review Ratings left anonymously by Bristol-Myers Squibb employees, which is 5% higher than the average rating for all companies on CareerBliss.
Is Bristol-Myers Squibb stock a Buy, Sell or Hold?
Bristol-Myers Squibb stock has received a consensus rating of buy. The average rating score is and is based on 13 buy ratings, 10 hold ratings, and...
What was the 52-week low for Bristol-Myers Squibb stock?
The low in the last 52 weeks of Bristol-Myers Squibb stock was 53.22. According to the current price, Bristol-Myers Squibb is 141.09% away from the...
What was the 52-week high for Bristol-Myers Squibb stock?
The high in the last 52 weeks of Bristol-Myers Squibb stock was 78.60. According to the current price, Bristol-Myers Squibb is 95.53% away from the...
What are analysts forecasts for Bristol-Myers Squibb stock?
The 25 analysts offering price forecasts for Bristol-Myers Squibb have a median target of 68.57, with a high estimate of 92.00 and a low estimate o...
Where is BMS headquartered?
Where is BMS located?
Reported on 4/28/21. Bristol Myers Squibb is an American multinational pharmaceutical company, headquartered in New York City . BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had the total revenue of $39.3 billion.
What is BMS pharmaceutical?
Bristol Myers Squibb is an American multinational pharmaceutical company, headquartered in New York City . BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations.
What is a key stat?
About. . Bristol Myers Squibb is an American multinational pharmaceutical company , headquartered in New York City. BMS is one of the world's largest pharmaceutical companies, and is consistently ranked on the Fortune 500 list of the largest U.S. corporations. As of September 2020, it had the total revenue of $39.3 billion.
How long are futures trading delayed?
Key stats. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Bristol Myers Squibb is an American multinational pharmaceutical company, headquartered in New York City.
How to calculate restricted stock?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
When is Bristol Myers Squibb's dividend?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
How much does Bristol Myers Squibb make?
Bristol-Myers Squibb announced a quarterly dividend on Thursday, June 17th. Shareholders of record on Friday, July 2nd will be given a dividend of $0.49 per share on Monday, August 2nd. This represents a $1.96 dividend on an annualized basis and a dividend yield of 2.90%. The ex-dividend date is Thursday, July 1st.
What is the company that makes Revlimid?
Bristol-Myers Squibb has a market capitalization of $150.94 billion and generates $42.52 billion in revenue each year. The biopharmaceutical company earns $-9,015,000,000.00 in net income (profit) each year or $6.44 on an earnings per share basis.
What is the consensus rating for Bristol Myers Squibb?
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Opdivo for anti-cancer indications; Eliquis, an oral inhibitor indicated for the reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; and Orencia for adult patients with active RA and psoriatic arthritis, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. The company also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a solvent-free protein-bound chemotherapy product; mpliciti for the treatment of multiple myeloma; and Reblozyl for the treatment of anemia in adult patients with beta thalassemia. In addition, it offers Onureg for the continued treatment of adult patients with AML; Zeposia to treat relapsing forms of multiple sclerosis; Vidaza for the treatment of myelodysplastic syndrome subtypes; Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B; and Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma. The company sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. It has collaboration agreements with Pfizer, Inc.; Otsuka Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Nektar Therapeutics; AVEO Pharmaceuticals, Inc.; Huyabio; and DarwinHealth, Inc. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
Does Bristol Myers have a dividend?
Bristol-Myers Squibb has received a consensus rating of Buy. The company's average rating score is 2.86, and is based on 10 buy ratings, 3 hold ratings, and no sell ratings.
